Company Filing History:
Years Active: 2020
Title: Per Harald Fuglerud: Innovator in Photodynamic Therapy
Introduction
Per Harald Fuglerud is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of photodynamic therapy through his innovative research and development. His work focuses on the use of aminolevulinic acid and its derivatives, which have important applications in medical treatments.
Latest Patents
Fuglerud holds a patent for the use of aminolevulinic acid and derivatives thereof. This invention provides a photosensitizer that is a derivative of 5-aminolevulinic acid (5-ALA) or a pharmaceutically acceptable salt. The patent outlines its use in the manufacture of a composition for photodynamic therapy (PDT) on animals, aiming to prevent or reduce side effects associated with the treatment.
Career Highlights
Fuglerud is associated with Photocure ASA, a company that specializes in developing innovative solutions for photodynamic therapy. His work has been instrumental in advancing the understanding and application of PDT in clinical settings. With one patent to his name, he continues to contribute to the field through research and development.
Collaborations
Fuglerud has collaborated with notable colleagues such as Hans Christian Wulf and Aslak Godal. These partnerships have enhanced the research efforts in photodynamic therapy and have led to advancements in treatment methodologies.
Conclusion
Per Harald Fuglerud is a key figure in the field of photodynamic therapy, with a focus on aminolevulinic acid derivatives. His contributions through patents and collaborations continue to influence medical treatments and improve patient outcomes.